Not known Factual Statements About phenobarbital sodium drug class
Not known Factual Statements About phenobarbital sodium drug class
Blog Article
pentobarbital will lower the extent or effect of parecoxib by impacting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Monitor.
Keep an eye on Closely (2)pentobarbital will decrease the extent or effect of buprenorphine, lengthy-performing injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Clients who transfer to buprenorphine extended-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers needs to be monitored to ensure buprenorphine plasma stages are sufficient.
Animal info. Phenobarbital sodium is carcinogenic in mice and rats just after lifetime administration. In mice, it generated benign and malignant liver mobile tumors. In rats, benign liver cell tumors were being noticed very late in life.
pentobarbital will lower the level or effect of verapamil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
Contraindicated (one)pentobarbital decreases amounts of panobinostat by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Robust CYP3A4 inducers can decrease panobinostat ranges by ~70% and bring about remedy failure.
pentobarbital will decrease the extent or effect of fosphenytoin by influencing hepatic enzyme CYP2C9/10 metabolism. Use Warning/Check.
pentobarbital will lower the extent or effect of methadone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lower the extent or effect of alfentanil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unfamiliar.
pentobarbital will minimize the level or effect of nilotinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
Use in pregnancy: Barbiturates can cause fetal harm when administered to some Expecting woman. Retrospective, scenario-controlled studies have suggested a link in between the maternal consumption of barbiturates and a better than predicted incidence of fetal abnormalities. Following oral or parenteral administration, barbiturates conveniently cross the placental barrier and therefore are distributed through fetal tissues with greatest concentrations present in the placenta, fetal liver, and Mind.
pentobarbital will lessen the extent or effect of clozapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
Check Intently (one)pentobarbital will decrease click here the level or effect of fentanyl by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Coadministration of fentanyl with CYP3A4 inducers may lead to some reduce in fentanyl plasma concentrations, lack of efficacy or, maybe, advancement of a withdrawal syndrome in a very individual who has produced Bodily dependence to fentanyl. Soon after halting a CYP3A4 inducer, because the effects with the inducer drop, the fentanyl plasma concentration will maximize which could boost or extend both of those the therapeutic and adverse effects.
pentobarbital will decrease the level or effect of tolterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital decreases amounts of ponatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Prevent Until the coadministration outweighs the doable chance of ponatinib underexposure; keep an eye on for signs of reduced efficacy.